Phenotypes associated with this allele
Allelic Composition |
Tcf3tm1Wein/Tcf3tm1Wein
|
|
Genetic Background |
either: (involves: 129 * 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6J) |
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tcf3tm1Wein mutation
(0 available);
any
Tcf3 mutation
(39 available)
|
|
|
mortality/aging
|
• pups appear normal at birth
• homozygotes usually die before weaning, most frequently in the first week
• death is preceded by cessation of growth, weight loss, and dehydration
|
growth/size/body
|
• growth is slower than normal, but appetite and feeding seems normal
• females are more severely affected than males
|
hematopoietic system
|
• the population of double positive CD4/CD8 cells in thymus gradually becomes reduced in 2-3 week old mice
|
|
• absence of B cells and precursors in E18.5 livers
• few or no B220 positive cells are present in bone marrow or spleen
• no IgM positive cells are found
|
|
• spleen degenerates in first three weeks of life
|
immune system
|
• the population of double positive CD4/CD8 cells in thymus gradually becomes reduced in 2-3 week old mice
|
|
• absence of B cells and precursors in E18.5 livers
• few or no B220 positive cells are present in bone marrow or spleen
• no IgM positive cells are found
|
|
• spleen degenerates in first three weeks of life
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tcf3tm1Wein mutation
(0 available);
any
Tcf3 mutation
(39 available)
|
|
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tcf3tm1Wein mutation
(0 available);
any
Tcf3 mutation
(39 available)
|
|
|
mortality/aging
|
• a small number of homozygous mice survive to about 10 months
|
neoplasm
|
• mice developing tumors were hunchbacked, skinny, and physically weak
• tumor cells found in blood, lymphoid, and non lymphoid organs
• tumor cells either lacked T-cell receptors or had only low levels
|
immune system
hematopoietic system
endocrine/exocrine glands
|
• mice developing tumors were hunchbacked, skinny, and physically weak
• tumor cells found in blood, lymphoid, and non lymphoid organs
• tumor cells either lacked T-cell receptors or had only low levels
|
Allelic Composition |
Tcf3tm1Wein/Tcf3+
|
|
Genetic Background |
either: (involves: 129/Sv * 129S4/SvJaeSor) or (involves: 129S4/SvJaeSor * C57BL/6J) |
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tcf3tm1Wein mutation
(0 available);
any
Tcf3 mutation
(39 available)
|
|
|
hematopoietic system
|
• B cell numbers reduced by half in the spleen but not the bone marrow
|
immune system
|
• B cell numbers reduced by half in the spleen but not the bone marrow
|
Allelic Composition |
Tcf3tm1Wein/Tcf3+
|
|
Genetic Background |
involves: 129S4/SvJaeSor |
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tcf3tm1Wein mutation
(0 available);
any
Tcf3 mutation
(39 available)
|
|
|
hematopoietic system
|
• the IgM+IgD- cell population is significantly reduced
• the IgM+IgD+ cell population is increased in the bone marrow
• the fraction of B cells expressing Ig-lambda is reduced
|
|
• the fraction of pre-B cells is reduced about 2 fold
|
immune system
|
• the IgM+IgD- cell population is significantly reduced
• the IgM+IgD+ cell population is increased in the bone marrow
• the fraction of B cells expressing Ig-lambda is reduced
|
|
• the fraction of pre-B cells is reduced about 2 fold
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tcf3tm1Wein mutation
(0 available);
any
Tcf3 mutation
(39 available)
Tcf3tm3Zhu mutation
(0 available);
any
Tcf3 mutation
(39 available)
|
|
|
mortality/aging
|
• postnatal survival is lower than normal but improved compared to Tcfe2a null mice
|
hematopoietic system
immune system
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tcf3tm1Wein mutation
(0 available);
any
Tcf3 mutation
(39 available)
Tcf4tm1Zhu mutation
(1 available);
any
Tcf4 mutation
(56 available)
|
|
|
mortality/aging
|
• most homozygotes died within two weeks of birth
|
growth/size/body
hematopoietic system
|
• 70% reduction in the number of pro-B cells
|
immune system
|
• 70% reduction in the number of pro-B cells
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Id1tm1Zhu mutation
(0 available);
any
Id1 mutation
(8 available)
Tcf3tm1Wein mutation
(0 available);
any
Tcf3 mutation
(39 available)
|
|
|
mortality/aging
|
• neonatal lethality observed in Tcf3tm1Wein homozygotes is partially rescued
|
|
• while fewer than expected mice are present at weaning, survival at weaning compared with Tcf3tm1Wein homozygotes is improved
|
immune system
|
• completely effaced by large immature lymphoblastic cells
|
|
• B cell development is blocked at the pro-B cell stage with no B220dull CD43+ cells detected in E18.5 fetal livers unlike in wild-type mice
|
|
• the lymphocyte population in the bone marrow is decreased compared to in wild-type mice
|
|
• due to large immature lymphoblastic cells
|
neoplasm
|
• after 3 months, all mice develop T cell tumors unlike in Id1tm1Zhu homozygotes
• tumors infiltrate the liver, pancreas, and kidney
|
growth/size/body
hematopoietic system
|
• completely effaced by large immature lymphoblastic cells
|
|
• B cell development is blocked at the pro-B cell stage with no B220dull CD43+ cells detected in E18.5 fetal livers unlike in wild-type mice
|
|
• the lymphocyte population in the bone marrow is decreased compared to in wild-type mice
|
|
• due to large immature lymphoblastic cells
|
endocrine/exocrine glands
|
• completely effaced by large immature lymphoblastic cells
|
|
• after 3 months, all mice develop T cell tumors unlike in Id1tm1Zhu homozygotes
• tumors infiltrate the liver, pancreas, and kidney
|
|
Find Mice |
Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tcf12tm1Zhu mutation
(0 available);
any
Tcf12 mutation
(74 available)
Tcf3tm1Wein mutation
(0 available);
any
Tcf3 mutation
(39 available)
|
|
|
mortality/aging
|
• most homozygotes died within two weeks of birth
|
growth/size/body
hematopoietic system
|
• 70% reduction in the number of pro-B cells
|
immune system
|
• 70% reduction in the number of pro-B cells
|